Should code 87620 (DELETED IN 2015), Infectious agent detection by nucleic acid (DNA or RNA); papillomavirus, human, direct probe technique, be reported when a human papillomavirus assay is performed by nucleic acid direct probe technique using an analyte specific reagent (ASR), or is this code only intended to identify this assay when an FDA-approved assay kit is used? ...
Subscribe or sign in to view the full article.
Article Overview
This premium article explains coding guidance for a human papillomavirus assay performed by nucleic acid direct probe technique. It is aimed at coding professionals who need to understand how assay material relates to CPT code selection and why the guidance matters for accurate reporting.
Why This Topic Matters
Accurate identification of the relevant CPT reporting approach helps coding staff apply consistent billing practices for laboratory testing and avoid uncertainty when different assay materials are used.
What You Will Learn
- The coding topic addressed by the article
- How the article frames CPT reporting for a human papillomavirus assay by direct probe technique
- The general issue of whether assay material affects code selection
- Why this guidance is relevant for laboratory coding decisions
Who Should Read This
- Medical coders
- Coding auditors
- Laboratory billing staff
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com